Bioprofiil & Teraapiad OÜ

Active Registry code 16976097 OÜ Tartu linn Registered 29 Apr 2024
Compare

Bioprofiil & Teraapiad OÜ is a OÜ based in Tartu linn, registry code 16976097, status: active. Main activity: Other human health activities n.e.c.. Its annual report for 2025 shows revenue of €5 820 and 0 employees.

Turnover
—
State taxes
—
Labour taxes
—
Employees
1
±0 vs Q2 2026

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Human health activities · EMTAK 86

  • Revenue · 2025 5 820 €
    industry median 20 811 € · companies in the industry: 3 373
  • Net profit margin · 2025 -25.6 %
    industry median 8.3 % · companies in the industry: 2 759

Taxes and turnover

Q2 2024 – Q3 2026
Labour taxes per employee, € Q4 2025: 362 € · industry median 2 236 € · above 7% of the industry
05001 0001 5002 0002 500Q2 2024 Company: 321 € Industry median: 2 205 €Q2·24Q3 2024 Company: 321 € Industry median: 2 205 €Q3·24Q4 2024 Company: 321 € Industry median: 2 146 €Q4·24Q1 2025 Company: — Industry median: 2 257 €Q1·25Q2 2025 Company: — Industry median: 2 253 €Q2·25Q3 2025 Company: — Industry median: 2 267 €Q3·25Q4 2025 Company: 362 € Industry median: 2 236 €Q4·25Q1 2026 Company: — Industry median: 2 195 €Q1·26Q2 2026 Company: — Industry median: 2 159 €Q2·26Q3 2026 Company: — Industry median: 2 177 €Q3·2605001 0001 5002 0002 500Q4 2024 Company: 321 € Industry median: 2 146 €Q1 2025 Company: — Industry median: 2 257 €Q1·25Q2 2025 Company: — Industry median: 2 253 €Q3 2025 Company: — Industry median: 2 267 €Q3·25Q4 2025 Company: 362 € Industry median: 2 236 €Q1 2026 Company: — Industry median: 2 195 €Q1·26Q2 2026 Company: — Industry median: 2 159 €Q3 2026 Company: — Industry median: 2 177 €Q3·26
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Employees Q3 2026: 1 · +0.0% vs Q2 2026
0.00.20.40.60.81.0Q2 2024 Company: 1Q2·24Q3 2024 Company: 1Q3·24Q4 2024 Company: 1Q4·24Q1 2025 Company: 1Q1·25Q2 2025 Company: 1Q2·25Q3 2025 Company: 1Q3·25Q4 2025 Company: 1Q4·25Q1 2026 Company: 1Q1·26Q2 2026 Company: 1Q2·26Q3 2026 Company: 1Q3·260.00.20.40.60.81.0Q4 2024 Company: 1Q1 2025 Company: 1Q1·25Q2 2025 Company: 1Q3 2025 Company: 1Q3·25Q4 2025 Company: 1Q1 2026 Company: 1Q1·26Q2 2026 Company: 1Q3 2026 Company: 1Q3·26
State taxes, € Q4 2025: 340 €
0100200300400Q2 2024 Company: 301 €Q2·24Q3 2024 Company: 301 €Q3·24Q4 2024 Company: 301 €Q4·24Q1 2025 Company: —Q1·25Q2 2025 Company: —Q2·25Q3 2025 Company: —Q3·25Q4 2025 Company: 340 €Q4·25Q1 2026 Company: —Q1·26Q2 2026 Company: —Q2·26Q3 2026 Company: —Q3·260100200300400Q4 2024 Company: 301 €Q1 2025 Company: —Q1·25Q2 2025 Company: —Q3 2025 Company: —Q3·25Q4 2025 Company: 340 €Q1 2026 Company: —Q1·26Q2 2026 Company: —Q3 2026 Company: —Q3·26
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q3 2026 — — — 1
Q2 2026 — — — 1
Q1 2026 — — — 1
Q4 2025 — 340 362 1
Q3 2025 — — — 1
Q2 2025 — — — 1
Q1 2025 — — — 1
Q4 2024 — 301 321 1
Q3 2024 — 301 321 1
Q2 2024 — 301 321 1

Financials by year

2024 – 2025
Revenue, € 2025: 5 820 € · −15.0% vs 2024 · industry median 20 811 € · above 34% of the industry
05 00010 00015 00020 00025 0002024 Company: 6 849 € Industry median: 20 000 €20242025 Company: 5 820 € Industry median: 20 811 €202505 00010 00015 00020 00025 0002024 Company: 6 849 € Industry median: 20 000 €2025 Company: 5 820 € Industry median: 20 811 €2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: -1 491 € · −199.9% vs 2024 · industry median 1 071 € · above 15% of the industry
-2 000-1 00001 0002 0002024 Company: 1 492 € Industry median: 1 621 €20242025 Company: -1 491 € Industry median: 1 071 €2025-2 000-1 00001 0002 0002024 Company: 1 492 € Industry median: 1 621 €2025 Company: -1 491 € Industry median: 1 071 €2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: -25.6 % · −47.4 pp vs the year before · industry median 8.3 % · above 8% of the industry
-30-20-1001020302024 Company: 21.8 % Industry median: 10.7 %20242025 Company: -25.6 % Industry median: 8.3 %2025-30-20-1001020302024 Company: 21.8 % Industry median: 10.7 %2025 Company: -25.6 % Industry median: 8.3 %2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 2 € · −99.9% vs 2024
05001 0001 5002024 Company: 1 493 €20242025 Company: 2 €202505001 0001 5002024 Company: 1 493 €2025 Company: 2 €2025
Equity, € 2025: 2 € · −99.9% vs 2024
05001 0001 5002024 Company: 1 493 €20242025 Company: 2 €202505001 0001 5002024 Company: 1 493 €2025 Company: 2 €2025
Employees 2025: 0 · industry median 2 · above 2% of the industry
0.00.51.01.52.02024 Company: 0 Industry median: 220242025 Company: 0 Industry median: 220250.00.51.01.52.02024 Company: 0 Industry median: 22025 Company: 0 Industry median: 22025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 5 820 -1 491 1 186 2 2 0
2024 6 849 1 492 3 291 1 493 1 493 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin
-25.6 %
Net profit / revenue
Return on equity (ROE)
-74 550.0 %
Net profit / equity
Return on assets (ROA)
-74 550.0 %
Net profit / assets
Equity ratio
100.0 %
Equity / assets

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 7 Apr 2026 Company’s own e-Äriregister
2024 29 Apr 2024 – 31 Dec 2024 28 Apr 2025 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

  • Andres Kurismaa
    Member of a senior management body (management or supervisory board) · since 29 Apr 2024

Founders and other persons

Activities (EMTAK)

  • 86992Other human health activities n.e.c. Main

Rulings 1

All rulings (PDF)
Rulings
Number, date Title Deadline State Document
Ä 50254098
29 Apr 2024
 First entry In force
29 Apr 2024
 PDF

Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data